Mesenchymal Stem Cell Homing to the Chronically Injured Liver

Research output

Research output per year 2010 2012 2013

• 14 Article

Research output per year

Research output per year

Search results

• 2010

  Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

  Armstrong, M., Houlihan, D. & Rowe, I., 16 Sept 2010, In: New England Journal of Medicine. 363, 12, p. 1185-1186 2 p.

  Research output: Contribution to journal › Article
  34 Citations (Scopus)
• 2011

  Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Liver Failure Patients Caused by Hepatitis B: Short-Term and Long-Term Outcomes

  Houlihan, D., Hopkins, L., Suresh, S., Armstrong, M. & Newsome, P., 1 Nov 2011, In: Hepatology. 54, 5, p. 1891-1892 2 p.

  Research output: Contribution to journal › Article
  14 Citations (Scopus)

• Prioritising treatment experienced patients with hepatitis C infection for treatment with telaprevir: A number needed to treat approach.

  Rowe, I., Armstrong, M. & Houlihan, D., 27 Dec 2011, In: Hepatology.

  Research output: Contribution to journal › Article
  1 Citation (Scopus)

• Renal function in patients transplanted for NASH cirrhosis: Time to reconsider immunosuppression regimens?

  Houlihan, D., Armstrong, M., Davidov, Y., Hodson, J., Nightingale, P., Rowe, I., Paris, S., Gunson, B., Bramhall, S., Mutimer, D., Neuberger, J. & Newsome, P., 14 Jul 2011, In: Liver Transplantation.

  Research output: Contribution to journal › Article

  • Fatty Liver 100%
  • Immunosuppression 84%
  • Fibrosis 69%
  • Liver Transplantation 66%
  • Kidney 50%
  56 Citations (Scopus)
• 2012

  Appropriateness of hepatitis a vaccination in patients with hepatitis C.

  Rowe, I., Parker, R. & Houlihan, D., 1 Mar 2012, In: The American Journal of Gastroenterology. 107, 3, p. 485 1 p.

  Research output: Contribution to journal › Article
  1 Citation (Scopus)

• Assessment of the quality of evidence underlying international guidelines in liver disease

  Rowe, I., Parker, R., Armstrong, M. J., King, A. L., Houlihan, D. & Mutimer, D., 2012, In: The American Journal of Gastroenterology. 107, 9, p. 1276-82 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Liver Diseases 100%
  • Guidelines 76%
  11 Citations (Scopus)

• Despite poor interferon response in advanced hepatitis C virus infection, models of protease inhibitor treatment predict maximum treatment benefit

  Rowe, I. A., Houlihan, D. D. & Mutimer, D. J., 2012, In: Alimentary Pharmacology & Therapeutics. 36, 7, p. 670-9 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Protease Inhibitors 100%
  • Hepacivirus 89%
  • Interferons 88%
  • Virus Diseases 71%
  • Uncertainty 44%
  5 Citations (Scopus)

• Hepatitis A virus vaccination in persons with hepatitis C virus infection: consequences of quality measure implementation.

  Rowe, I., Parker, R., Armstrong, M., Houlihan, D. & Mutimer, D., 28 Feb 2012, In: Hepatology. 56, 2, p. 501-506 6 p.

  Research output: Contribution to journal › Article

  • Hepatitis A virus 100%
  • Hepacivirus 71%
  • Superinfection 61%
  • Vaccination 61%
  • Virus Diseases 56%
  8 Citations (Scopus)

• Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis.

  Rowe, I., Armstrong, M., Parker, R. & Houlihan, D., 19 Jan 2012, In: Hepatology.

  Research output: Contribution to journal › Article

• Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort

  Armstrong, M., Houlihan, D., Bentham, L., Shaw, J., Cramb, R., Olliff, S., Gill, P., Neuberger, J., Lilford, R. & Newsome, P., 1 Jan 2012, In: Journal of Hepatology. 56, 1, p. 234-240 7 p.

  Research output: Contribution to journal › Article

  • Non-alcoholic Fatty Liver Disease 100%
  • Primary Health Care 73%
  • Fatty Liver 16%
  • Liver Cirrhosis 14%
  • Alcohol Drinking 14%
  181 Citations (Scopus)

• Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program

  Armstrong, M. J., Houlihan, D. D., Rowe, I. A., Clausen, W. H. O., Elbrønd, B., Gough, S. C. L., Tomlinson, J. W. & Newsome, P. N., 2012, In: Alimentary Pharmacology & Therapeutics.

  Research output: Contribution to journal › Article › peer-review

  • Liraglutide 100%
  • Type 2 Diabetes Mellitus 53%
  • Data Analysis 53%
  • Meta-Analysis 53%
  • Safety 41%
  145 Citations (Scopus)
• 2013

  Birmingham and Lambeth Liver Evaluation Testing Strategies (BALLETS): a prospective cohort study

  Lilford, R., Bentham, L., Girling, A., Litchfield, I., Lancashire, R., Armstrong, D., Jones, R., Marteau, T., Neuberger, J., Gill, P., Cramb, R., Olliff, S., Arnold, D., Khan, K., Armstrong, M., Houlihan, D., Newsome, P., Chilton, P., Moons, K., Altman, D., & 1 othersGill, P., Jul 2013, In: Health Technology Assessment. 17, 28, p. 1-307 307 p.

  Research output: Contribution to journal › Article › peer-review

  • Liver Function Tests 100%
  • General Practice 87%
  • Liver Diseases 74%
  • Cohort Studies 60%
  • Prospective Studies 56%
  27 Citations (Scopus)

• LNGFR+THY-1+VCAM-1hi+ cells reveal functionally distinct subpopulations in mesenchymal stem cells

  Mabuchi, Y., Morikawa, S., Harada, S., Niibe, K., Suzuki, S., Renault-mihara, F., Houlihan, D., Akazawa, C., Okano, H. & Matsuzaki, Y., 6 Aug 2013, In: Stem Cell Reports. 1, 2, p. 152-165

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Cell Surface Marker 100%
  • Clonogenic 92%
  • Heterogeneity 55%
  • Mesenchymal Stem Cells 53%
  • Marker 52%
  109 Citations (Scopus)

  369 Downloads (Pure)

• Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice

  Armstrong, M., Corbett, C., Hodson, J., Marwah, N., Parker, R., Houlihan, D. D., Rowe, I. A., Hazlehurst, J. M., Brown, R., Hubscher, S. G. & Mutimer, D., 1 Dec 2013, In: Postgraduate Medical Journal. 89, 1058, p. 685-692

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Liver 100%
  • Fibrosis 37%
  • Biopsy 12%
  • Learning Curve 11%
  • Liver Cirrhosis 9%
  19 Citations (Scopus)

  804 Downloads (Pure)